companydata.dkPAREXEL DENMARK A/S
CVR: 31588626
PAREXEL DENMARK A/S shows a positive financial trajectory, with revenue increasing from 36.37 million DKK in 2023 to 37.69 million DKK in 2024, alongside a significant rise in profit from 1.17 million DKK to 2.33 million DKK. The company's equity has also strengthened, climbing from 15.43 million DKK in 2023 to 17.76 million DKK in 2024, indicating solid financial health and a growing capital base. While the profit margins are improving, the revenue in 2022 was higher at 39.83 million DKK, suggesting a potential area for growth to regain previous highs. Overall, PAREXEL DENMARK A/S is positioned well within the administrative and office services industry, benefiting from a robust equity position and increasing profitability.
AI-generated summary
Overview
Details
Purpose
Selskabets formål er at drive virksomhed inden for den farmaceutiske, biotekniske og medicinske produktionsindustri, herunder men ikke begrænset til kliniske forsøg, samt anden hermed forbundet virksomhed.
Location
Financials
| Year | Revenue | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 2024 | 37.7 mio. | 2.3 mio. | 22.6 mio. | 17.8 mio. | 20 | |
History
Ownership
Management
Directors
Board
Founders
Production units (1)
Similar companies
Companies in the same industry and area